Efficacy and safety of monoclonal antibody PEP for rabies

Lancet. 2025 Aug 9;406(10503):578-579. doi: 10.1016/S0140-6736(25)01199-7.

Authors

Corine H GeurtsvanKessel¹, Leo G Visser²

Affiliations

¹ Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands.
² Leiden University Center for Infectious Diseases, Subdepartment of Infectious Diseases, Leiden University Medical Center, Leiden 2333, Netherlands. Electronic address: l.g.visser@lumc.nl.

PMID: 40783279
DOI: 10.1016/S0140-6736(25)01199-7

No abstract available